Despite the recent successes in siRNA therapeutics, targeted delivery beyond the liver remains the major hurdle for the widespread application of siRNA in vivo. Current cationic liposome or polymer-based delivery agents are restricted to the liver and suffer from off-target effects, poor clearance, low serum stability, and high toxicity. In this study, we genetically engineered a non-cationic non-viral tumor-targeted universal siRNA nanocarrier (MW 26 KDa). This protein nanocarrier consists of three function domains: a dsRNA binding domain (dsRBD) (from human protein kinase R) for any siRNA binding, 18-histidine for endosome escape, and two RGD peptides at the N- and C-termini for targeting tumor and tumor neovasculature. We showed that cloned dual-RGD-dsRBD-18his (dual-RGD) protein protects siRNA against RNases, induces effective siRNA endosomal escape, specifically targets integrin αvβ3 expressing cells in vitro, and homes siRNA to tumors in vivo. The delivered siRNA leads to target gene knockdown in the cell lines and tumor xenografts with low toxicity. This multifunctional and biomimetic siRNA carrier is biodegradable, has low toxicity, is suitable for mass production by fermentation, and is serum stable, holding great potential to provide a widely applicable siRNA carrier for tumor-targeted siRNA delivery.
Vitamin D deficiency and magnesium deficiency are both associated with an increased risk of anemia. However, the impact of dietary magnesium intake on the relationship between vitamin D deficiency and anemia risk has yet to be determined. In this study, 11,471 children aged 2 to 14 years were enrolled using data from the National Health and Nutrition Examination Survey 2005 to 2018. The participants were divided into low and high magnesium intake groups based on a quantile cutoff of < 208.5 and ≥ 208.5 mg/d, respectively. Participants who were vitamin D deficiency had an increased risk of anemia (odds ratio = 1.492, 95% confidence intervals: 1.072–2.077). The incidence of anemia differed in low-dietary magnesium intake and high-dietary magnesium intake groups (odds ratio, 95% confidence interval: 1.992, 1.264–3.139 vs 0.934, 0.564–1.548, respectively), indicating an interaction between vitamin D deficiency and dietary magnesium intake in anemia risk ( P = .009), which suggests that a magnesium-rich diet may reduce the risk of vitamin D deficiency-induced anemia. the findings highlight the synergistic effect of low-dietary magnesium intake and vitamin D deficiency on the increased risk of anemia in children.
We updated affiliation 5 from “Dotquant LLC, CoMotion Labs at University of Washington, Seattle, WA 98195, USA” to “Dotquant LLC, Seattle, WA 98195, USA”, as CoMotion Labs at University of Washington is a start-up incubator